Nembutal Side Effects
Generic name: pentobarbital
Note: This document contains side effect information about pentobarbital. Some of the dosage forms listed on this page may not apply to the brand name Nembutal.
Some side effects of Nembutal may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.
For the Consumer
Applies to pentobarbital: parenteral solution for injection
Side effects include:
Residual sedation, drowsiness, lethargy, vertigo, nausea, vomiting, headache.
For Healthcare Professionals
Applies to pentobarbital: compounding powder, injectable solution, oral capsule, oral elixir, rectal suppository
Nervous system side effects have been common and have included drowsiness, sedation, lethargy, and somnolence. Paradoxical stimulation has also been reported in the elderly.
Behavioral problems, impaired memory, impaired cognition, decreased perceptuomotor performance, tics, dyskinesias, nystagmus, oculogyric crises, dystonic reactions, and ataxia have also been reported.
Respiratory side effects including life threatening respiratory depression have been reported, particularly during acute intoxication.
Other side effects from pentobarbital (the active ingredient contained in Nembutal) use have included physical and psychological dependence. Withdrawal symptoms have been reported when pentobarbital therapy has been discontinued suddenly.
Withdrawal symptoms may include hallucinations, sweating, insomnia, and hypertension.
An increased frequency of seizures may occur if barbiturate therapy is suddenly discontinued.
Cardiovascular side effects including hypotension and bradycardia have been reported.
Musculoskeletal side effects including myopathy in association with anticonvulsant osteomalacia has been reported in patients taking other barbiturates. Reflex sympathetic dystrophy of the upper extremities, Dupuytren's contractures, Peyronie's disease, the "shoulder-hand syndrome" and other musculoskeletal and joint pains have been reported in as many as 5% of patients treated with other barbiturates.
Hypersensitivity side effects have included a variety of hypersensitivity reactions reported in association with use of pentobarbital (the active ingredient contained in Nembutal) and other barbiturates. The reactions frequently involved generalized rashes, fever, and hepatic derangements.
The more serious hepatic effects have often been reported in association with hypersensitivity reactions.
Hepatic side effects including elevated liver function tests, hepatitis, cholestasis, and fulminant hepatic failure have all been reported in association with use of other barbiturates.
Hematologic side effects including macrocytosis and, more rarely, megaloblastic anemia have been reported with use of other barbiturates.
Animal studies have suggested that pentobarbital may inhibit prostaglandin l2 and thereby promote platelet aggregation.
Endocrine side effects including alterations in vitamin D metabolism have been reported in patients taking barbiturates and other anticonvulsants. Hypocalcemia and osteomalacia have been specifically reported.
Oncologic side effects have been reported. Some investigators have reported a possible increased frequency of malignancy (particularly brain tumors, lung cancer, and liver cancer) in patients taking pentobarbital (the active ingredient contained in Nembutal) and other barbiturates chronically. Other investigators have not found an association with malignancy.
More Nembutal resources
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.